Symposium in Immunology Vi: Tumor Immunology by Martha M. EiblSymposium in Immunology Vi: Tumor Immunology by Martha M. Eibl

Symposium in Immunology Vi: Tumor Immunology

byMartha M. EiblEditorChristoph Huber, Hans H. Peter

Paperback | February 20, 1997

Pricing and Purchase Info


Earn 896 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


This is the sixth symposium in a series of symposia on immunology organized by IMMUNO covering this time tumor immunology. This volume deals with T cell recognition and CD95-associating signaling, clinical investigations: cells, costimulatory signals and therapeutic approaches: cytokines and vaccines.
Title:Symposium in Immunology Vi: Tumor ImmunologyFormat:PaperbackDimensions:172 pages, 23.5 × 15.5 × 0.07 inPublished:February 20, 1997Publisher:Springer Nature

The following ISBNs are associated with this title:

ISBN - 10:3540617558

ISBN - 13:9783540617556

Look for similar items by category:


Table of Contents

T Cell Recognition and CD95-Associating Signalling.- Characterization of Antigens Recognized by T Cells on Human Tumors.- Shared and Individual CTL-Defined Antigens on Human Melanoma Cells.- Deficiencies of the MHC Class I Antigen Processing and Presentation Machinery in Tumor Cells.- The Use of HLA Transgenic Mice in Identifying and Targeting Human Tumor Cell Antigens.- CD95-Associating Signaling Molecules.- Clinical Investigations: Cells, Costimulatory Signals.- Adoptive Immunotherapy in Chimeras.- Towards the Development of Immunogenic Colon Cancer Cells for Immunotherapy.- Gene-Modified Dendritic Cells as Vaccines for the Induction of Anti-Tumor Immunity.- Potent Presentation of Soluble Protein Antigens by In Vitro-Generated Dendritic Cells from Peripheral Blood CD34+ Progenitor Cells.- Therapeutic Approaches: Cytokines and Vaccines.- Interleukin-12: Biology and Clinical Studies.- Peptide Vaccines in Melanoma Patients.- Ras Peptide Vaccines.- Idiotype-Based Immunotherapy of Cancers.- Heat-Shock-Protein-Based Vaccines against Cancers and Intracellular Infections.